$MFIN
MEDALLION FINANCIAL CORP

2023 Q4 Form 10-Q Financial Statement

#000095017023059368 Filed on November 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $65.89M
YoY Change 27.45%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.343M $1.400M
YoY Change 63.58% -10.49%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $17.10M
YoY Change 77.15%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $22.16M $19.47M
YoY Change 12.79% 57.61%
Income Tax $6.328M $6.727M
% Of Pretax Income 28.56% 34.55%
Net Earnings $14.32M $11.23M
YoY Change 9.61% 47.05%
Net Earnings / Revenue 17.04%
Basic Earnings Per Share $0.50
Diluted Earnings Per Share $0.60 $0.48
COMMON SHARES
Basic Shares Outstanding 23.36M 23.36M
Diluted Shares Outstanding 23.39M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.9M $90.65M
YoY Change 30.87% 23.99%
Cash & Equivalents $52.59M $37.47M
Short-Term Investments $54.28M $53.18M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $14.08M $13.30M
YoY Change 6.9% 5.25%
Goodwill $150.8M $150.8M
YoY Change 0.0% 0.0%
Intangibles $20.59M $20.95M
YoY Change -6.55% -6.46%
Long-Term Investments $65.71M $10.54M
YoY Change 538.41% -82.14%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.588B $2.559B
YoY Change 14.51% 16.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.63M $34.40M
YoY Change 47.41% 902.33%
Accrued Expenses $7.019M $9.300M
YoY Change -34.08% 8.39%
Deferred Revenue
YoY Change
Short-Term Debt $8.000M $18.49M
YoY Change 60.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.64M $65.10M
YoY Change 45.54% 361.47%
LONG-TERM LIABILITIES
Long-Term Debt $235.5M $218.1M
YoY Change 9.9% -0.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $235.5M $218.1M
YoY Change 9.9% -0.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.64M $65.10M
Total Long-Term Liabilities $235.5M $218.1M
Total Liabilities $2.245B $2.161B
YoY Change 18.82% 13.25%
SHAREHOLDERS EQUITY
Retained Earnings $103.9M $91.90M
YoY Change 55.81% 65.77%
Common Stock $288.3M $287.1M
YoY Change 1.54% 1.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $45.54M $45.54M
YoY Change 0.0% 4.11%
Treasury Stock Shares
Shareholders Equity $343.0M $328.5M
YoY Change
Total Liabilities & Shareholders Equity $2.588B $2.559B
YoY Change 14.51% 16.33%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $14.32M $11.23M
YoY Change 9.61% 47.05%
Depreciation, Depletion And Amortization $1.343M $1.400M
YoY Change 63.58% -10.49%
Cash From Operating Activities $19.66M $35.80M
YoY Change -33.9% 29.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$12.50M -$62.90M
YoY Change -81.69% -51.81%
Cash From Investing Activities -$12.50M -$62.90M
YoY Change -81.69% -51.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.08M 30.10M
YoY Change -67.14% -59.78%
NET CHANGE
Cash From Operating Activities 19.66M 35.80M
Cash From Investing Activities -12.50M -62.90M
Cash From Financing Activities 15.08M 30.10M
Net Change In Cash 22.25M 3.000M
YoY Change 200.8% -110.67%
FREE CASH FLOW
Cash From Operating Activities $19.66M $35.80M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001000209
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2028-09-30
CY2021Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-02-28
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20230930#PropertyEquipmentAndRightOfUseAssetNet
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20230930#PropertyEquipmentAndRightOfUseAssetNet
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37747
dei Entity Registrant Name
EntityRegistrantName
MEDALLION FINANCIAL CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3291176
dei Entity Address Address Line1
EntityAddressAddressLine1
437 MADISON AVENUE, 38th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
328-2100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
MFIN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23363731
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37472000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33172000
CY2023Q3 us-gaap Federal Funds Sold
FederalFundsSold
90170000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
72426000
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
53175000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
48492000
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
10542000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10293000
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203038000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1916953000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79133000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
63845000
CY2023Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2123905000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1853108000
CY2023Q3 us-gaap Goodwill
Goodwill
150803000
CY2022Q4 us-gaap Goodwill
Goodwill
150803000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20952000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22035000
CY2023Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
15923000
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
21819000
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
13593000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5602154
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
45538000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
12613000
CY2023Q3 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
13278000
CY2022Q4 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
13168000
CY2023Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
0
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
2095000
CY2023Q3 us-gaap Other Assets
OtherAssets
28814000
CY2022Q4 us-gaap Other Assets
OtherAssets
19855000
CY2023Q3 us-gaap Assets
Assets
2558627000
CY2022Q4 us-gaap Assets
Assets
2259879000
CY2023Q3 us-gaap Deposits
Deposits
1855096000
CY2022Q4 us-gaap Deposits
Deposits
1607110000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
218137000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
214320000
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
18489000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5000000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23131000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26753000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7075000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8408000
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4624000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4790000
CY2023Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2866000
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
0
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
31947000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
22974000
CY2023Q3 us-gaap Liabilities
Liabilities
2161365000
CY2022Q4 us-gaap Liabilities
Liabilities
1889355000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28965885
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28663827
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
290000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
287000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
286782000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
283663000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5602154
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
45538000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4960000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3349000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
91900000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
66673000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
328474000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
301736000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
68788000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
68788000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397262000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
370524000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2558627000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2259879000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23363731
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23061673
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.06
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.08
CY2023Q3 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
6200000
CY2022Q4 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
7500000
CY2023Q3 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2022Q4 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
64608000
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
50955000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
179407000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
140759000
CY2023Q3 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
1278000
CY2022Q3 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
739000
mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
4048000
mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
1349000
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
65886000
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
51694000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
183455000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
142108000
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
13432000
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
6240000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
33360000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
15306000
CY2023Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
2901000
CY2022Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3414000
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
8694000
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
9952000
CY2023Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
769000
CY2022Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
0
us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
2325000
us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
0
CY2023Q3 us-gaap Interest Expense
InterestExpense
17102000
CY2022Q3 us-gaap Interest Expense
InterestExpense
9654000
us-gaap Interest Expense
InterestExpense
44379000
us-gaap Interest Expense
InterestExpense
25258000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
48784000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42040000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
139076000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
116850000
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
14532000
CY2022Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
10047000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
27045000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
21046000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
34252000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
31993000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
112031000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
95804000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1417000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
518000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
4578000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
5061000
CY2023Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2180000
CY2022Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-1123000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2189000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2985000
CY2023Q3 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
30000
CY2022Q3 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
94000
mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
303000
mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
608000
CY2023Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
739000
CY2022Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
468000
us-gaap Noninterest Income Other
NoninterestIncomeOther
1868000
us-gaap Noninterest Income Other
NoninterestIncomeOther
1217000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
4306000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
-231000
us-gaap Noninterest Income
NoninterestIncome
8332000
us-gaap Noninterest Income
NoninterestIncome
8655000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
9630000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
8411000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
27805000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
23709000
CY2023Q3 mfin Loan Servicing Fee
LoanServicingFee
2501000
CY2022Q3 mfin Loan Servicing Fee
LoanServicingFee
2159000
mfin Loan Servicing Fee
LoanServicingFee
7084000
mfin Loan Servicing Fee
LoanServicingFee
6231000
CY2023Q3 mfin Collection Costs
CollectionCosts
1583000
CY2022Q3 mfin Collection Costs
CollectionCosts
1593000
mfin Collection Costs
CollectionCosts
4729000
mfin Collection Costs
CollectionCosts
3935000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
1148000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
3722000
us-gaap Professional Fees
ProfessionalFees
4223000
us-gaap Professional Fees
ProfessionalFees
12106000
CY2023Q3 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
629000
CY2022Q3 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
629000
mfin Lease And Rental Expense1
LeaseAndRentalExpense1
1855000
mfin Lease And Rental Expense1
LeaseAndRentalExpense1
1764000
CY2023Q3 mfin Regulatory Fees
RegulatoryFees
1021000
CY2022Q3 mfin Regulatory Fees
RegulatoryFees
610000
mfin Regulatory Fees
RegulatoryFees
2484000
mfin Regulatory Fees
RegulatoryFees
1621000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
361000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
359000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1084000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1082000
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2216000
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1926000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
7220000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
5807000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
19089000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
19409000
us-gaap Noninterest Expense
NoninterestExpense
56484000
us-gaap Noninterest Expense
NoninterestExpense
56255000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19469000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12353000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63879000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48204000
CY2023Q3 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
6727000
CY2022Q3 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
3205000
mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
18582000
mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
12892000
CY2023Q3 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
12742000
CY2022Q3 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
9148000
mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
45297000
mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
35312000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4536000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4535000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
11230000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
7636000
us-gaap Net Income Loss
NetIncomeLoss
40761000
us-gaap Net Income Loss
NetIncomeLoss
30777000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22596982
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23154775
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22469968
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24020058
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23392901
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23510645
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23067944
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24332776
CY2023Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
400000
us-gaap Paid In Kind Interest
PaidInKindInterest
1100000
CY2022Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
200000
us-gaap Paid In Kind Interest
PaidInKindInterest
500000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
12742000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
9148000
us-gaap Profit Loss
ProfitLoss
45297000
us-gaap Profit Loss
ProfitLoss
35312000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1211000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1461000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1611000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4596000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11531000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7687000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
43686000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
30716000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1512000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1512000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4536000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4535000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10019000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6175000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39150000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26181000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
370524000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
16873000
CY2023Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1036000
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-768000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
292000
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1863000
CY2023Q1 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
506000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
375153000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
15682000
CY2023Q2 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1214000
CY2023Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1867000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-906000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
387764000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
12742000
CY2023Q3 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1232000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
116000
CY2023Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1869000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1211000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397262000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355828000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2022Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
598000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
152000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
617000
CY2022Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2044000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1717000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362041000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
14811000
CY2022Q2 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1511000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
863000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9974000
CY2022Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1971000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1418000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362841000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
9148000
CY2022Q3 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1034000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8231000
CY2022Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2022Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1930000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1461000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359889000
us-gaap Profit Loss
ProfitLoss
45297000
us-gaap Profit Loss
ProfitLoss
35312000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
27045000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
21046000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
1086000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
528000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3878000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4408000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-7279000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-7184000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
5116000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
5335000
mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-6673000
mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-3806000
mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
-3136000
mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
2985000
us-gaap Share Based Compensation
ShareBasedCompensation
3482000
us-gaap Share Based Compensation
ShareBasedCompensation
2495000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
980000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
1338000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13033000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5641000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7500000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9858000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-166000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
37000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94141000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78989000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
805048000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
806788000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
471917000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
414760000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10169000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
18658000
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
467000
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
11970000
mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
14607000
mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
17952000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-328226000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-380764000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
683568000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
676264000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
417084000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
371800000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5459000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5766000
mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
4536000
mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
4535000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
768000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
18822000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
408000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
152000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
256129000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
275493000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22044000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26282000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
105598000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
124484000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127642000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98202000
us-gaap Interest Paid Net
InterestPaidNet
42054000
us-gaap Interest Paid Net
InterestPaidNet
23177000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12822000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5786000
mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
15384000
mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
8659000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S., or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1300000
CY2023Q3 mfin Non Marketable Securities
NonMarketableSecurities
10500000
CY2022Q4 mfin Non Marketable Securities
NonMarketableSecurities
10300000
CY2023Q3 mfin Impact Of Equity Investment
ImpactOfEquityInvestment
3400000
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1700000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1700000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-54000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-77000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-54000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-229000
CY2023Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2022Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-54000
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-77000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-54000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-229000
mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
41000000
CY2022 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
34900000
CY2023Q3 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
2200000
mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
6500000
CY2022Q3 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
2300000
mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
6800000
CY2023Q1 mfin Loans Charged Off
LoansChargedOff
2500000
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
79500
CY2023Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
15600000
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
19500000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
63845000
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2023Q3 us-gaap Goodwill
Goodwill
150800000
CY2022Q4 us-gaap Goodwill
Goodwill
150800000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21000000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22000000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20952000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22035000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000
CY2023Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
800000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2300000
CY2022Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
700000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2000000
CY2023Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
8200000
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7000000
CY2023Q3 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
11230000
CY2022Q3 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
7636000
mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
40761000
mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
30777000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22596982
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23154775
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22469968
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24020058
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
481197
CY2022Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
307318
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
413682
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
238621
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
183274
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
48552
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
125319
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
74097
CY2023Q3 mfin Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits
131448
CY2022Q3 mfin Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits
0
mfin Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits
58975
mfin Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits
0
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23392901
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23510645
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23067944
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24332776
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
657579
CY2023Q3 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.105
CY2023Q3 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.10
CY2023Q3 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.176
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
296444
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1200000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3500000
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.05
us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.15
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1000000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2500000
CY2022Q3 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.04
us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.1
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5400000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P10M
CY2023Q3 mfin Tier One Leverage Capital Required For Capital Adequacy To Total Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets
0.15
CY2023Q3 mfin Tier One Leverage Capital Ratio
TierOneLeverageCapitalRatio
0.161
CY2023Q3 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
283342000
CY2022Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
242049000
CY2023Q3 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
352130000
CY2022Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
310837000
CY2023Q3 us-gaap Capital
Capital
379754000
CY2022Q4 us-gaap Capital
Capital
334913000
mfin Average Assets
AverageAssets
2190234000
CY2022 mfin Average Assets
AverageAssets
1917904000
CY2023Q3 us-gaap Risk Weighted Assets
RiskWeightedAssets
2162430000
CY2022Q4 us-gaap Risk Weighted Assets
RiskWeightedAssets
1888530000
CY2023Q3 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.04
CY2023Q3 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.05
CY2023Q3 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.161
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.162
CY2023Q3 mfin Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.07
CY2023Q3 mfin Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2023Q3 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.131
CY2022Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.128
mfin Tier One Risk Based Capital Required For Capital Adequacy With Buffer To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyWithBufferToRiskWeightedAssets
0.085
CY2023Q3 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2023Q3 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.163
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.165
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.177
CY2023Q3 mfin Effects Of The Transition Amount In Capital
EffectsOfTheTransitionAmountInCapital
6200000
mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
CY2022 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span></p>
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
61222000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8059000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
53175000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
54301000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5822000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48492000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2429000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2341000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
7373000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6970000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
8938000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
7558000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
42482000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
36306000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
61222000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
53175000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
493000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
10579000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
7566000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
42553000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1017000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
16949000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4805000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
29525000
CY2023Q3 mfin Number Of Securities
NumberOfSecurities
62
CY2022Q4 mfin Number Of Securities
NumberOfSecurities
57
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
74971000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
59152000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
63845000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2023Q3 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
15574000
CY2022Q3 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
13171000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
46533000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
27139000
CY2023Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
5204000
CY2022Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
5507000
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
21064000
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
17462000
CY2023Q3 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
10370000
CY2022Q3 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
7664000
us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
25469000
us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
9677000
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
14532000
CY2022Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
10047000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
27045000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
21046000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79133000
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
61535000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79133000
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
61535000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
1854000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
6370000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
2983000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
1333000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
1379000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
1655000
CY2023Q3 mfin Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Write Off1
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteOff1
15574000
us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
1937000
us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
15998000
us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
9498000
us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
4090000
us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
4973000
us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff
10037000
mfin Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Write Off1
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteOff1
46533000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79133000
CY2023Q3 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2023Q3 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0359
CY2023Q3 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
3.8325
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
63845000
CY2022Q4 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2022Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0333
CY2022Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
1.9869
CY2023Q3 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
20648000
CY2022Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
32133000
mfin Interest Foregone Quarter To Date
InterestForegoneQuarterToDate
190000
CY2022 mfin Interest Foregone Quarter To Date
InterestForegoneQuarterToDate
231000
mfin Amount Of Foregone Interest Applied To Principal In The Quarter
AmountOfForegoneInterestAppliedToPrincipalInTheQuarter
49000
CY2022 mfin Amount Of Foregone Interest Applied To Principal In The Quarter
AmountOfForegoneInterestAppliedToPrincipalInTheQuarter
94000
mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
618000
CY2022 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
1267000
mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
183000
CY2022 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
375000
mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
1837000
CY2022 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
2419000
mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
839000
CY2022 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
1204000
CY2023Q3 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.009
CY2022Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.017
CY2023Q3 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
3.832
CY2022Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.987
CY2023Q3 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
2203038000
mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0094
CY2022Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1916953000
CY2022 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.017
CY2023Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
20648000
CY2023Q3 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
21487000
CY2023Q3 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
3107000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
32550000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
33754000
CY2022Q4 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
10806000
CY2023Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
14997000
CY2023Q3 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
9000
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
37099000
CY2022Q3 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
114000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
17189000
mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
12000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
37174000
mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
303000
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
58288000
CY2023Q3 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2163877000
CY2023Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
41000000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
57618000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1882585000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2022 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
34900000
CY2023Q3 mfin Loan To Value Ratio
LoanToValueRatio
1.89
CY2022Q4 mfin Loan To Value Ratio
LoanToValueRatio
3.39
CY2023Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
16803000
CY2023Q3 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
4730000
CY2023Q3 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
1197000
CY2023Q3 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
2102000
CY2023Q3 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
2311000
CY2023Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
15923000
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
21819000
mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
15384000
mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
6543000
mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
8064000
mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
6673000
CY2023Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
15923000
CY2022Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
26974000
CY2022Q3 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
2862000
CY2022Q3 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-1943000
CY2022Q3 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-2243000
CY2022Q3 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-1319000
CY2022Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
24331000
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000
mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
8659000
mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-8456000
mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-9496000
mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-3806000
CY2022Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
24331000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
737465000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
582943000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
331120000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
169466000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
210424000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
67000000
CY2023Q3 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
2098418000
CY2022Q4 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1832184000
CY2023Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0335
CY2023Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
8200000
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7000000
CY2023Q3 mfin Reserve Deposits
ReserveDeposits
1500000
CY2022Q4 mfin Reserve Deposits
ReserveDeposits
1300000
CY2023Q3 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
12100000
CY2022Q4 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
12400000
CY2023Q3 us-gaap Deposits Retail
DepositsRetail
18000000
CY2023Q3 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Or Less
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess
204577000
CY2023Q3 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths
157064000
CY2023Q3 us-gaap Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months
ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months
357335000
CY2023Q3 us-gaap Contractual Maturities Time Deposits100000 Or More After12 Months
ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months
1140203000
CY2023Q3 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
1859179000
CY2019Q3 us-gaap Notes Payable
NotesPayable
6000000
CY2007Q4 us-gaap Payments For Repurchase Of Trust Preferred Securities
PaymentsForRepurchaseOfTrustPreferredSecurities
2000000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
597000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
580000
us-gaap Operating Lease Cost
OperatingLeaseCost
1792000
us-gaap Operating Lease Cost
OperatingLeaseCost
1759000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
629000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
684000
us-gaap Operating Lease Payments
OperatingLeasePayments
1855000
us-gaap Operating Lease Payments
OperatingLeasePayments
1764000
CY2023Q3 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-56000
CY2022Q3 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-47000
mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-167000
mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-133000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8505000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9723000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2193000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2239000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7075000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8408000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9268000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10647000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0559
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0566
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
629000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2508000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2492000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2440000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1213000
CY2023Q3 mfin Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1290000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10572000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1304000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9268000
CY2023Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43125000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43397000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
11491000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
9945000
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3804000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3730000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
6038000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
3819000
CY2023Q3 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
-2094000
CY2022Q4 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
-1445000
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
19698000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24458000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3433000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
23131000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
26753000
CY2023Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5893000
CY2022Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
693000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
12349000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2181000
CY2023Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1753000
CY2022Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
340000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3717000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1109000
CY2023Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-689000
CY2022Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2081000
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1761000
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7679000
CY2023Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-230000
CY2022Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
91000
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
755000
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1923000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6727000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3205000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18582000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12892000
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4088000
CY2022Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2613000
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
13414000
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10142000
CY2023Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
800000
CY2022Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
511000
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2624000
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1984000
CY2023Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
624000
CY2022Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
410000
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1701000
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1484000
CY2023Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1138000
CY2022Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1138000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2023Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-77000
CY2022Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
329000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
295000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
718000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6727000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3205000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18582000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12892000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
965146
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
702886
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1111687
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
26093
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.08
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23745
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.51
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1061849
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
9.38
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.51
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25194
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.97
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44583
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.55
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
992072
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
9.38
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.53
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
7803
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.31
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
283
CY2023Q2 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice
4.89
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.89
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
983986
CY2023Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2023Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
9.38
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.5
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q3 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2023Q3 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePrice
0
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18840
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.17
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
965146
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
9.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.51
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
548426
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedExercisePriceRangeLowerRangeLimit
2.14
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedExercisePriceRangeUpperRangeLimit
9.38
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.51
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
702886
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedExercisePriceRangeLowerRangeLimit
2.14
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Vested Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedExercisePriceRangeUpperRangeLimit
9.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.51
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
500000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M6D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
513423
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.52
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
2951
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
4.89
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
5.53
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
248212
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit
4.89
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
7.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.55
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
262260
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.49
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2023Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2023Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
262260
CY2023Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2023Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.49
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
0
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
0
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
262260
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2023Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
158937
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
mfin Number Of Non Operating Segments
NumberOfNonOperatingSegments
1
CY2023Q3 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
65886000
CY2023Q3 mfin Interest Expense Net
InterestExpenseNet
17102000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
48784000
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
14532000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
34252000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
4306000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
19089000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19469000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6727000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
12742000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
11230000
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203038000
CY2023Q3 us-gaap Assets
Assets
2558627000
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2099919000
CY2023Q3 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0201
CY2023Q3 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1289
CY2023Q3 mfin Percentage Of Return On Average Stockholders Equity
PercentageOfReturnOnAverageStockholdersEquity
0.138
CY2023Q3 mfin Interest Yield
InterestYield
0.1128
CY2023Q3 mfin Net Interest Margin Gross Percentage1
NetInterestMarginGrossPercentage1
0.0835
CY2023Q3 mfin Net Interest Margin Net Of Allowance Percentage
NetInterestMarginNetOfAllowancePercentage
0.0864
CY2023Q3 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0359
CY2023Q3 mfin Delinquency Status
DelinquencyStatus
0.0032
CY2023Q3 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0188
mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
183455000
mfin Interest Expense Net
InterestExpenseNet
44379000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
139076000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
27045000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
112031000
us-gaap Noninterest Income
NoninterestIncome
8332000
us-gaap Noninterest Expense
NoninterestExpense
56484000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63879000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18582000
us-gaap Profit Loss
ProfitLoss
45297000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4536000
us-gaap Net Income Loss
NetIncomeLoss
40761000
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203038000
CY2023Q3 us-gaap Assets
Assets
2558627000
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2099919000
mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0252
mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.159
mfin Percentage Of Return On Average Stockholders Equity
PercentageOfReturnOnAverageStockholdersEquity
0.1749
mfin Interest Yield
InterestYield
0.111
mfin Net Interest Margin Gross Percentage1
NetInterestMarginGrossPercentage1
0.0842
mfin Net Interest Margin Net Of Allowance Percentage
NetInterestMarginNetOfAllowancePercentage
0.0871
mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0359
mfin Delinquency Status
DelinquencyStatus
0.0032
mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0165
CY2022Q3 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
51694000
CY2022Q3 mfin Interest Expense Net
InterestExpenseNet
9654000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42040000
CY2022Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
10047000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
31993000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
-231000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
19409000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12353000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3205000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
9148000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
7636000
CY2022Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1855510000
CY2022Q3 us-gaap Assets
Assets
2199541000
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1808597000
CY2022Q3 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0168
CY2022Q3 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1003
CY2022Q3 mfin Percentage Of Return On Average Stockholders Equity
PercentageOfReturnOnAverageStockholdersEquity
0.1035
CY2022Q3 mfin Interest Yield
InterestYield
0.1061
CY2022Q3 mfin Net Interest Margin Gross Percentage1
NetInterestMarginGrossPercentage1
0.0863
CY2022Q3 mfin Net Interest Margin Net Of Allowance Percentage
NetInterestMarginNetOfAllowancePercentage
0.0891
CY2022Q3 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0332
CY2022Q3 mfin Delinquency Status
DelinquencyStatus
0.0033
CY2022Q3 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0169
mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
142108000
mfin Interest Expense Net
InterestExpenseNet
25258000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
116850000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
21046000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
95804000
us-gaap Noninterest Income
NoninterestIncome
8655000
us-gaap Noninterest Expense
NoninterestExpense
56255000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48204000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12892000
us-gaap Profit Loss
ProfitLoss
35312000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4535000
us-gaap Net Income Loss
NetIncomeLoss
30777000
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1855510000
CY2022Q3 us-gaap Assets
Assets
2199541000
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1808597000
mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0233
mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1305
mfin Percentage Of Return On Average Stockholders Equity
PercentageOfReturnOnAverageStockholdersEquity
0.1406
mfin Interest Yield
InterestYield
0.1069
mfin Net Interest Margin Gross Percentage1
NetInterestMarginGrossPercentage1
0.0879
mfin Net Interest Margin Net Of Allowance Percentage
NetInterestMarginNetOfAllowancePercentage
0.0909
mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0332
mfin Delinquency Status
DelinquencyStatus
0.0033
mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0078
mfin Employment Agreement Description
EmploymentAgreementDescription
employment agreements expire at various dates through 2027
CY2023Q3 mfin Employment Agreements Future Minimum Payments Due
EmploymentAgreementsFutureMinimumPaymentsDue
11000000
CY2023Q3 us-gaap Other Commitment
OtherCommitment
0
CY2023Q3 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-1200000
mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-1600000
CY2022 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-4400000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
mfin-20230930_cal.xml Edgar Link unprocessable
mfin-20230930_def.xml Edgar Link unprocessable
mfin-20230930_lab.xml Edgar Link unprocessable
0000950170-23-059368-index-headers.html Edgar Link pending
0000950170-23-059368-index.html Edgar Link pending
0000950170-23-059368.txt Edgar Link pending
0000950170-23-059368-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mfin-20230930.htm Edgar Link pending
mfin-20230930.xsd Edgar Link pending
mfin-ex31_1.htm Edgar Link pending
mfin-ex31_2.htm Edgar Link pending
mfin-20230930_pre.xml Edgar Link unprocessable
mfin-20230930_htm.xml Edgar Link completed
mfin-ex32_1.htm Edgar Link pending
mfin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending